Phillip Frost, CEO & Chairman, Director, Ten Percent Owner at Opko Health, holds 1.73M shares in Cocrystal Pharma (Ticker: COCP), holds 250.40M shares in Opko Health (Ticker: OPK), holds 1.49M shares in Nocopi Technologies (Ticker: NNUP). Most recently, Phillip Frost Bought ― shares of Cocrystal Pharma on Nov 28, 2025 for an estimated value of $3.98K.
Phillip Frost latest transaction was an Informative Buy of $3.98K.
What was Phillip Frost's most profitable transaction?
Phillip Frost’s most profitable transaction was an Informative Buy of OPK stock on April 2, 2020. The return on the trade was 280.80%.
What is Phillip Frost's role in Opko Health?
Phillip Frost's role in Opko Health is CEO & Chairman, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.